200 related articles for article (PubMed ID: 15964522)
1. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
[TBL] [Abstract][Full Text] [Related]
3. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
Nordeng H; Lindemann R; Perminov KV; Reikvam A
Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
[TBL] [Abstract][Full Text] [Related]
4. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
[No Abstract] [Full Text] [Related]
6. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
8. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
de Moor RA; Mourad L; ter Haar J; Egberts AC
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
10. Neonatal complications after intrauterine exposure to SSRI antidepressants.
Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.
Sanz EJ; De-las-Cuevas C; Kiuru A; Bate A; Edwards R
Lancet; 2005 Feb 5-11; 365(9458):482-7. PubMed ID: 15705457
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Withdrawal Syndrome following Late in utero Exposure to Selective Serotonin Reuptake Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies.
Wang J; Cosci F
Psychother Psychosom; 2021; 90(5):299-307. PubMed ID: 33971648
[TBL] [Abstract][Full Text] [Related]
14. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
15. SSRIs and the developing brain.
Ruchkin V; Martin A
Lancet; 2005 Feb 5-11; 365(9458):451-3. PubMed ID: 15705440
[No Abstract] [Full Text] [Related]
16. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine and neonatal withdrawal syndrome.
Pogliani L; Schneider L; Dilillo D; Penagini F; Zuccotti GV
BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736561
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
[TBL] [Abstract][Full Text] [Related]
19. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Grzeskowiak LE; Gilbert AL; Morrison JL
J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
Koren G; Finkelstein Y; Matsui D; Berkovich M
J Obstet Gynaecol Can; 2009 Apr; 31(4):348-350. PubMed ID: 19497154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
